Trial Profile
Epidemiology, Correlation and Predictive Value of Disease Activity and Biomarkers in RA [rheumatoid arthritis] Patients Initiated on Infliximab in Clinical Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms REMARK
- Sponsors Merck Sharp & Dohme Corp.
- 09 Jun 2010 Patient numbers amended from (694) to (728) as reported by ClinicalTrials.go
- 29 Sep 2008 Actual patient number (694) added as reported by ClinicalTrials.gov.
- 29 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.